Analysis of the correlation between KRT17 and clinic-pathological features of LSCC patients (Table 2) uncovered that KRT17 expression was remarkably correlated with differentiation (P < 0.001), T classification (P < 0.01), lymph node metastasis (P < 0.05), and clinical stage (P < 0.05). The gene discussed is KRT17; the disease is metastatic malignant neoplasm in the lymph nodes.